ESH 2022 - Mandelieu-La Napoule, France

24th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy

VIDEOS

The potential of targeting PAK6 in CML - Andrew Wu -ESH 2022
October 31  2022, VJHemOnc – Video Journal of Hematological Oncology

Recommendations for treatment discontinuation in CML – Dr. F-X Mahon
October 27, 2022,V JHemOnc – Video Journal of Hematological Oncology

The use of BCR:ABL1 digital PCR to identify patients with CML suitable for early TKI discontinuation
October 22,  2022, VJHemOnc – Video Journal of Hematological Oncology

Key topics at ESH CML 2022 (Dr. Jorge Cortes)
October 21, 2022,  VJHemOnc – Video Journal of Hematological Oncology

Measuring residual disease in granulocytes to predict relapse after therapy cessation in CML
October 21, 2022, VJHemOnc – Video Journal of Hematological Oncology

Is hematopoietic cell transplantation in CML still relevant in 2022? Robert Peter Gale (ESH 2022)
October  21, 2022,  VJHemOnc – Video Journal of Hematological Oncology